The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Purpose
To estimate the efficacy and safety of ocriplasmin for patients with vitreous macular traction (VMT).
Methods
The PubMed, EMBASE and Ovid were searched up to May 2020 to identify related studies. Statistical analysis was conducted by R software version 3.6.3. Results in proportion with 95% confidence interval (CI) were calculated by means of Freeman–Tukey variant of arcsine square transformation...
Purpose
To evaluate the efficacy and safety of different agents, dosages and strategies of anti‐vascular endothelial growth factor (VEGF) treatment for neovascular age‐related macular degeneration (nAMD) by network meta‐analysis.
Methods
Electronic database searches were conducted on PubMed, Embase and Cochrane Central Register of Controlled Trials up to 1 December 2019 to `identify relevant randomized...